PFN2
Profilin-2
Also known as: PROF2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35080
- Gene
- PFN2
- Ensembl
- ENSG00000070087
- Chromosome
- 3
- Canonical length
- 140 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
The protein encoded by this gene is a ubiquitous actin monomer-binding protein belonging to the profilin family. It is thought to regulate actin polymerization in response to extracellular signals. There are two alternatively spliced transcript variants encoding different isoforms described for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
140 residues, UniProt reviewed canonical sequence.
>P35080|PFN2
1 MAGWQSYVDN LMCDGCCQEA AIVGYCDAKY VWAATAGGVF QSITPIEIDM IVGKDREGFF
61 TNGLTLGAKK CSVIRDSLYV DGDCTMDIRT KSQGGEPTYN VAVGRAGRVL VFVMGKEGVH
121 GGGLNKKAYS MAKYLRDSGFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PFN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 342 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 342 nTPM
- hippocampal formation: 270 nTPM
- amygdala: 252 nTPM
- skeletal muscle: 252 nTPM
- basal ganglia: 216 nTPM
- hypothalamus: 177 nTPM
Single-cell type
- myonuclei: 71 nCPM
- cardiomyocytes: 63 nCPM
- early spermatids: 32 nCPM
- epicardial cells: 30 nCPM
- undifferentiated spermatogonia: 26 nCPM
- late primary spermatocytes: 25 nCPM
Immune cell
- naive CD4 T-cell: 6.3 nTPM
- memory CD4 T-cell: 4.3 nTPM
- MAIT T-cell: 4.2 nTPM
- naive CD8 T-cell: 4.2 nTPM
- memory CD8 T-cell: 3.6 nTPM
- gdT-cell: 2.1 nTPM
Brain region
- hippocampal formation: 477 nTPM
- cerebral cortex: 374 nTPM
- basal ganglia: 314 nTPM
- white matter: 283 nTPM
- hypothalamus: 258 nTPM
- amygdala: 230 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0.42
- gnomAD missense Z
- 1.97
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- modification of postsynaptic actin cytoskeleton
- negative regulation of epithelial cell migration
- negative regulation of ruffle assembly
- positive regulation of actin filament bundle assembly
- positive regulation of actin filament polymerization
- positive regulation of stress fiber assembly
- presynaptic actin cytoskeleton organization
- presynaptic modulation of chemical synaptic transmission
- protein stabilization
- regulation of actin filament polymerization
- regulation of synaptic vesicle exocytosis
Molecular functions
- actin binding
- actin monomer binding
- ATP hydrolysis activity
- phosphatidylinositol-4,5-bisphosphate binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PFN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PFN2 as an antibody target. Whether an autoantibody or antibody against PFN2 could matter depends on whether native PFN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PFN2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PFN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...